Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Virological Response and Drug Resistance 1 and 2 Years Post-Partum in HIV-Infected Women Initiated on Life-Long Antiretroviral Therapy in Malawi.

AIDS research and human retroviruses - 1 Aug 2016

Mancinelli Sandro, Galluzzo Clementina Maria, Andreotti Mauro, Liotta Giuseppe, Jere Haswel, Sagno Jean-Baptiste, Amici Roberta, Pirillo Maria Franca, Scarcella Paola, Marazzi Maria Cristina, Vella Stefano, Palombi Leonardo, Giuliano Marina

Abstract excerpt

The objective of this study was to determine the virological response and the possible emergence of drug resistance at 1 and 2 years postpartum in HIV-positive pregnant women enrolled under the Option B approach and meeting the criteria for treatment. In the study, women with baseline CD4(+) <350/mm(3) received a combination of stavudine, lamivudine, and nevirapine during pregnancy (from week 25 of gestation) and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiretroviral Therapy, Highly Active
Share to Gestational Age

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Infectious Disease Transmission, Vertical

Share to Lamivudine

Share to Malawi

Share to Nevirapine

Share to Postpartum Period

Share to Stavudine

Source

Identifiers

PMID: 27067142
DOI: 10.1089/AID.2015.0366

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Virological Response and Drug Resistance 1 and 2 Years Post-Partum in HIV-Infected Women Initiated on Life-Long Antiretroviral Therapy in Malawi.PMID 27067142Read ↗

Drug resistance mutations 18 months after discontinuation of nevirapine-based ART for prevention of mother-to-child transmission of HIV in Malawi.Semantic proximity Read ↗

Decreased emergence of HIV-1 drug resistance mutations in a cohort of Ugandan women initiating option B+ for PMTCT.Semantic proximity Read ↗

Addition of 7 days of zidovudine plus lamivudine to peripartum single-dose nevirapine effectively reduces nevirapine resistance postpartum in HIV-infected mothers in Malawi.Semantic proximity Read ↗

Resistance levels to non-nucleoside reverse transcriptase inhibitors among pregnant women with recent HIV infection in Malawi.Semantic proximity Read ↗

Emergence of HIV-1 drug-resistant variants in women following antiretroviral prophylaxis for the prevention of mother to child transmission.Semantic proximity Read ↗

Emergence of lamivudine resistance hepatitis B virus mutations in pregnant women infected with HBV and HIV receiving antiretroviral prophylaxis for the prevention of mother-to-infant transmission in Malawi.Semantic proximity Read ↗

Emergence of minor drug-resistant HIV-1 variants after triple antiretroviral prophylaxis for prevention of vertical HIV-1 transmission.Semantic proximity Read ↗

High level of HIV-1 resistance in patients failing long-term first-line antiretroviral therapy in Mali.Semantic proximity Read ↗

Initiation of antiretroviral treatment in women after delivery can induce multiclass drug resistance in breastfeeding HIV-infected infants.Semantic proximity Read ↗

High rates of baseline antiretroviral resistance among HIV-infected pregnant women in an HIV referral centre in Rio de Janeiro, Brazil.Semantic proximity Read ↗

Viral Suppression and Resistance in a Cohort of Perinatally-HIV Infected (PHIV+) Pregnant Women.Semantic proximity Read ↗

HIV genotypic resistance among pregnant women initiating ART in Uganda: a baseline evaluation of participants in the Option B+ clinical trial.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.